Evidence map›Paper›PMID 33649601›Full record

ArticleNature chemical biology2021

Oncohistone mutations enhance chromatin remodeling and alter cell fates.

John D Bagert, Michelle M Mitchener, Agata L Patriotis, Barbara E Dul, Felix Wojcik, Benjamin A Nacev, Lijuan Feng, C David Allis, Tom W Muir

Open access · greenAbstract read
In one paragraph

Article in Nature chemical biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 1 pooled it
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 1 synthesis or guideline pooled it, 103 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Nuclear destabilisation - a possible genesis of cancer?Biological reviews of the Cambridge Philosophical Society · 2025
    Review
  9. Article
  10. Article
  11. Engineered histones reshape chromatin in human cells.bioRxiv : the preprint server for biology · 2025
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

John D Bagert *Department of Chemistry, Princeton University, Princeton, NJ, USA.ORCID http://orcid.org/0000-0001-7768-2853
Michelle M Mitchener *Department of Chemistry, Princeton University, Princeton, NJ, USA.ORCID http://orcid.org/0000-0001-5036-2286
Agata L PatriotisLaboratory of Chromatin Biology and Epigenetics, The Rockefeller University, New York, NY, USA.
Barbara E DulDepartment of Chemistry, Princeton University, Princeton, NJ, USA.ORCID http://orcid.org/0000-0003-2451-9053
Felix WojcikDepartment of Chemistry, Princeton University, Princeton, NJ, USA.ORCID http://orcid.org/0000-0003-3444-6468
Benjamin A NacevLaboratory of Chromatin Biology and Epigenetics, The Rockefeller University, New York, NY, USA.
Lijuan FengLaboratory of Chromatin Biology and Epigenetics, The Rockefeller University, New York, NY, USA.
C David AllisLaboratory of Chromatin Biology and Epigenetics, The Rockefeller University, New York, NY, USA. alliscd@mail.rockefeller.edu.ORCID http://orcid.org/0000-0001-7589-713X
Tom W MuirDepartment of Chemistry, Princeton University, Princeton, NJ, USA. muir@princeton.edu.ORCID http://orcid.org/0000-0001-9635-0344
Princeton University · USRockefeller University · USMemorial Sloan Kettering Cancer Center · USNovo Nordisk (Denmark) · DK

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Targeting Oncogenic Pathways in Genetically Complex SarcomasP50CA217694 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Marc Ladanyi · 2018 to 2026
$21.5M
Shared Resources Core 2: Quantitative Proteomics CoreP01CA196539 · NCI · ROCKEFELLER UNIVERSITY · PI YOUNG, MICHAEL WARREN · 2015 to 2024
$17.6M
Structure, Function and Applications of InteinsR37GM086868 · NIGMS · PRINCETON UNIVERSITY · PI MUIR, TOM · 2012 to 2021
$5.4M
Structure, Function and Applications of InteinsR01GM086868 · NIGMS · ROCKEFELLER UNIVERSITY · PI MUIR, TOM · 2008 to 2025
$4.4M
Structure-activity relationships governing mammalian SWI/SNF chromatin remodeling activity as a function of chromatin stateR01CA259365 · NCI · DANA-FARBER CANCER INST · PI Cigall Kadoch, Tom Muir · 2021 to 2026
$4.2M
Elucidating and targeting the effects of oncogenic histone mutationsK08CA245212 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI NACEV, BENJAMIN A · 2019 to 2023
$1.4M
Investigating the Cellular and Biochemical Consequences of Novel OncohistonesF32GM131632 · NIGMS · PRINCETON UNIVERSITY · PI MITCHENER, MICHELLE · 2019 to 2021
$195k
Exploring second-tier post-translational modifications in chromatin biology: A new class of histone modifications with undetermined functionF32GM123659 · NIGMS · PRINCETON UNIVERSITY · PI BAGERT, JOHN DAVID · 2017 to 2018
$118k
NCI NIH HHS K08 CA245212NCI NIH HHS P01 CA196539NCI NIH HHS P30 CA008748NCI NIH HHS P50 CA217694NCI NIH HHS R01 CA259365NIGMS NIH HHS F32 GM123659NIGMS NIH HHS F32 GM131632NIGMS NIH HHS R01 GM086868NIGMS NIH HHS R37 GM086868
6 · The paper itself

Abstract

Whole-genome sequencing data mining efforts have revealed numerous histone mutations in a wide range of cancer types. These occur in all four core histones in both the tail and globular domains and remain largely uncharacterized. Here we used two high-throughput approaches, a DNA-barcoded mononucleosome library and a humanized yeast library, to profile the biochemical and cellular effects of these mutations. We identified cancer-associated mutations in the histone globular domains that enhance fundamental chromatin remodeling processes, histone exchange and nucleosome sliding, and are lethal in yeast. In mammalian cells, these mutations upregulate cancer-associated gene pathways and inhibit cellular differentiation by altering expression of lineage-specific transcription factors. This work represents a comprehensive functional analysis of the histone mutational landscape in human cancers and leads to a model in which histone mutations that perturb nucleosome remodeling may contribute to disease development and/or progression.

Indexed as

AnimalsCell DifferentiationChromatinChromatin Assembly and DisassemblyGene LibraryHistonesHumansMutationNeoplasmsNucleosomesProtein BindingProtein DomainsTranscriptional ActivationTranscription FactorsChromatinHistonesNucleosomesTranscription Factors

Identifiers

PMID33649601
PMCPMC8174649
OpenAlexW3133570715

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.